Journal
ONCOTARGET
Volume 8, Issue 50, Pages 87763-87772Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.21193
Keywords
neuroblastoma; LCL161; vincristine; NF kappa B; G2 cell cycle arrest
Categories
Ask authors/readers for more resources
We demonstrated sensitization for chemotherapy by Smac mimetic (SM) LCL161, a potent antagonist of inhibitor of apoptosis proteins (IAP), in neuroblastoma (NB). Vinca alkaloids, particularly vincristine (VCR), displayed the strongest impact on inhibition of proliferation and apoptosis induction in combination with LCL161. The underlying signaling pathways remain elusive, though. LCL161 induces a quick degradation of cellular IAP 1 (cIAP-1). Combination of LCL161 with VCR had only marginal effects on X-linked IAP (XIAP) protein expression. Cell death is accompanied by activation of intrinsic (caspase-9 and MMP) and extrinsic (caspase-8) pathways of apoptosis, repression of migratory potential and cell cycle arrest in G2 phase. LCL161-induced cIAP degradation leads to activation of non-canonical and blockade of canonical NF-kappa B pathways but not induction of apoptosis. Surprisingly NF kappa B and TNF-alpha signaling is negligible for VCR-and VCR/LCL161-induced apoptosis since chemical inhibition of NF-kappa B using BAY-7085 and PBS-1086, as well as application of TNF-a blocking antibody Humira (adalimumab) has no relevant effect on cell death. Recently formation of a TNF-alpha-independent complex (ripoptosome) consisting of RIP1, FADD and caspase-8 following IAP inhibition by SM has been described. However, targeting of RIP1 by Necrostatin was not sufficient to influence apoptosis induced by VCR/LCL161.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available